Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
BH-AC-DMP protocol
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
BH-AC-DMP protocol
Unique ID
C046633
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C046633
Entry Term(s)
AML89 protocol
Registry Numbers
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
/
analogs & derivatives
Daunorubicin
Prednisolone
Mercaptopurine
Frequency
39
Note
chemotherapy protocol consisting of N(4)-behenoyl-ara-C, daunorubicin, 6-mercaptopurine & prednisolone; the induction phase of JALSG AML89 protocol
Source
Rinsho Ketsueki 1985;26(4):494
Date of Entry
1985/10/30
Revision Date
2013/11/06
Expand All
Collapse All
BH-AC-DMP protocol
Preferred
Concept UI
M0135025
Registry Numbers
0
Terms
BH-AC-DMP protocol
Preferred Term
Term UI
T165030
Date
01/01/1955
LexicalTag
NON
ThesaurusID
NLM (1985)
AML89 protocol
Term UI
T165029
Date
01/01/1955
LexicalTag
NON
ThesaurusID
NLM (1985)
page delivered in 0.004s